Market by Drug Class, Application, and Country | Forecast 2019-2028
As per Triton's research report, the Middle East and African dermatological therapeutics market would surge with a CAGR of 7.47% in the forecasting years of 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries reviewed
in this market include:
• Saudi Arabia
• The United Arab Emirates
• Turkey
• South Africa
• Rest of MEA
The presence of several
international derma-health companies and a flourishing medical tourism industry
are factors attracting numerous investors and patients to the MEA region,
especially the UAE and Saudi Arabia. Though, due to the COVID-19 outbreak this year,
the medical tourism industry has been at its lowest point, this situation is
expected to improve gradually, thereby putting the region’s dermatological
therapeutics market back on the growth track in the forecasting period.
In Saudi Arabia, a
five-year retrospective study published in the Journal of Dermatology and
Dermatological Surgery by Fawwaz Al Shammrie, in 2017, suggests that, eczema is
the most commonly occurring dermatological disease in the country. Further,
there is also a high rate of incidence of acne, atopic dermatitis, alopecia,
and psoriasis, among others.
Moreover, the renowned
pharmaceutical R&D company, AbbVie, organized a "Best of the American
Academy of Dermatology" event in Saudi Arabia in 2019. It was learnt that,
several Saudi-based patients, who have psoriasis, reported the disease to have
majorly hampered their quality of life. There were an estimated 500,000
patients affected by psoriasis at the time, with one-third of these cases
ranging from moderate to severe. The high prevalence of dermatological diseases
in the KSA has significantly enhanced the demand for dermatological treatments
and therapeutics. This, along with the growth in the country’s geriatric
population, is propelling Saudi’s dermatological therapeutics market to expand
in the coming years.
Merck & Co
develops, manufactures, and markets pharmaceutical and biological prescription
drugs for the treatment of various health conditions. The company has strong
research and development (R&D) capabilities. Its RonaCare range offers
creams for various skin health issues. Merck has a notable business presence in
the Middle East and Africa.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. KEY
INSIGHTS
2.2.1. ADVANCEMENTS
IN BIOLOGICS
2.2.2. ATOPIC
DERMATITIS IS ANTICIPATED TO GROW AT HIGHEST CAGR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. IMPACT
OF COVID-19 – DERMATOLOGICAL THERAPEUTICS
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. MARKET
DRIVERS
2.7.1. INCREASING
BURDEN OF DERMATOLOGICAL DISEASES
2.8. MARKET
RESTRAINTS
2.8.1. GRAVE
SIDE-EFFECTS FOR CERTAIN CLASSES OF THERAPEUTIC DRUGS
2.9. MARKET
OPPORTUNITIES
2.9.1. RISE
IN AWARENESS LEVELS OF DISEASE ORIGIN AND PROGRESSION
2.10. MARKET
CHALLENGES
2.10.1.
UNAWARENESS TOWARDS
DERMATOLOGICAL DIAGNOSIS
3. MIDDLE
EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK – BY DRUG CLASS
3.1. ANTI-INFECTIVES
3.2. CORTICOSTEROIDS
3.3. ANTI-ACNE
3.4. CALCINEURIN
INHIBITORS
3.5. RETINOIDS
3.6. OTHER
DRUG CLASSES
4. MIDDLE
EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK - BY APPLICATION
4.1. ALOPECIA
4.2. HERPES
4.3. PSORIASIS
4.4. ROSACEA
4.5. ATOPIC
DERMATITIS
4.6. ACNE
VULGARIS
4.7. OTHER
APPLICATIONS
5. MIDDLE
EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET – REGIONAL OUTLOOK
5.1. MIDDLE
EAST AND AFRICA
5.1.1. UNITED
ARAB EMIRATES
5.1.2. TURKEY
5.1.3. SAUDI
ARABIA
5.1.4. SOUTH
AFRICA
5.1.5. REST
OF MIDDLE EAST & AFRICA
6. COMPETITIVE
LANDSCAPE
6.1. ABBVIE
INC
6.2. ALLERGAN
6.3. ALMIRALL
6.4. AMGEN
INC
6.5. BAUSCH
HEALTH COMPANIES INC
6.6. GALDERMA
6.7. GLAXOSMITHKLINE
PLC
6.8. JOHNSON
& JOHNSON
6.9. NOVARTIS
AG
6.10. PFIZER
INC
6.11. AGI
DERMATICS
6.12. LEO
PHARMA A/S
6.13. MERCK
& CO
7. METHODOLOGY
& SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND AFRICA DERMATOLOGICAL
THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: MIDDLE EAST AND AFRICA DERMATOLOGICAL
THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 5: MIDDLE EAST AND AFRICA DERMATOLOGICAL
THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)
TABLE 6: MIDDLE EAST AND AFRICA DERMATOLOGICAL
THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)
FIGURE 1: PORTER’S FIVE
FORCES ANALYSIS
FIGURE 2: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028
(IN $ BILLION)
FIGURE 3: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028
(IN $ BILLION)
FIGURE 4: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $
BILLION)
FIGURE 5: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS,
2019-2028 (IN $ BILLION)
FIGURE 6: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $
BILLION)
FIGURE 7: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028
(IN $ BILLION)
FIGURE 8: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $
BILLION)
FIGURE 9: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $
BILLION)
FIGURE 10: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $
BILLION)
FIGURE 11: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $
BILLION)
FIGURE 12: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS, 2019-2028
(IN $ BILLION)
FIGURE 13: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN
$ BILLION)
FIGURE 14: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028
(IN $ BILLION)
FIGURE 15: MIDDLE EAST
AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028
(IN %)
FIGURE 16: UNITED ARAB
EMIRATES DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 17: TURKEY
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 18: SAUDI ARABIA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 19: SOUTH AFRICA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 20: REST OF
MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $
BILLION)